Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-10

FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved Ajanta Pharma USA Inc.'s original ANDA for fenofibrate, a generic lipid-lowering medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

ORIG AP for FENOFIBRATE (FENOFIBRATE)